Quest PharmaTech Inc.
QPTFF
Rank in Stocks
#30432
Quest PharmaTech Inc. (QPTFF), an Edmonton, Canada-based pharmaceutical firm,... Quest PharmaTech Inc. (QPTFF), an Edmonton, Canada-based pharmaceutical firm, specializes in creating antibody-driven immunotherapeutic remedies primarily for various cancers. A cornerstone of its product pipeline is Mab AR 9.6, an advanced therapeutic candidate specifically designed to target truncated O-glycans on MUC16 for precise cancer treatment applications. The company's offerings further encompass Oregovomab, an anti-CA-125 antibody that has successfully completed Phase II clinical trials for the management of ovarian cancer. Beyond these specific agents, Quest PharmaTech is actively involved in the development, manufacturing, and commercialization of new immunotherapy products aimed at combating pancreatic cancer. The organization also diversifies its portfolio by utilizing proprietary transdermal delivery technologies to formulate products for dermatological conditions and wound healing. Additionally, it develops specialized skin-penetrating active molecules for use in both cosmetic and pharmaceutical goods. Rounding out its innovative efforts, Quest PharmaTech designs intricate combinatorial immunotherapies for cancer, employing monoclonal antibodies belonging to both immunoglobulin G and E classes.
Share Price
$0.03
Last synced: 2026-11-10
Market Cap
$5.07M
Change (1 day)
0.00%
Change (1 year)
125.56%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Quest PharmaTech Inc. (QPTFF)
Category
Healthcare
EPS for Quest PharmaTech Inc. (QPTFF)
EPS as of July 2026 TTM: $0.02
According to Quest PharmaTech Inc.'s latest financial reports, its current EPS (TTM) is $0.02. At the end of 2025 the company had an EPS of $-0.01, equal to its 2024 EPS of $-0.01.
EPS history for Quest PharmaTech Inc. from 2001 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.02 | -289.00% |
| 2025 | $-0.01 | -48.98% |
| 2024 | $-0.01 | -60.16% |
| 2023 | $-0.02 | -92.18% |
| 2022 | $-0.31 | -145.26% |
| 2021 | $0.70 | -3,394.31% |
| 2020 | $-0.02 | 38.82% |
| 2019 | $-0.02 | -27.96% |
| 2018 | $-0.02 | 124.47% |
| 2017 | $-0.01 | -51.30% |
| 2016 | $-0.02 | 83.81% |
| 2015 | $-0.01 | 337.50% |
| 2014 | 0.00 | -87.94% |
| 2012 | $-0.02 | -0.50% |
| 2011 | $-0.02 | 127.27% |
| 2010 | $-0.01 | 363.16% |
| 2009 | 0.00 | -90.40% |
| 2008 | $-0.02 | -31.01% |
| 2007 | $-0.03 | 0.00% |
| 2005 | 0.00 | 0.00% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | 0.00% |
| 2002 | 0.00 | 0.00% |
| 2001 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.89 | -4,808.99% |
US
|
|
| $15.66 | 82,757.14% |
US
|
|
| $-7.07 | -37,507.41% |
US
|
|
| $-5.29 | -28,089.42% |
AU
|
|
| $12.73 | 67,266.14% |
BE
|
Questions about Quest PharmaTech Inc.'s earnings per share (EPS)
What is Quest PharmaTech Inc.'s earnings per share (EPS)?
Quest PharmaTech Inc.'s earnings per share (EPS) over the last twelve months is $0.02, as of Jul 2026.
What was Quest PharmaTech Inc.'s earnings per share (EPS) in 2025?
In 2025, Quest PharmaTech Inc.'s earnings per share (EPS) was $-0.01, compared with $-0.01 in 2024.
How has Quest PharmaTech Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Quest PharmaTech Inc.'s earnings per share (EPS) was highest in 2021 ($0.70) and lowest in 2022 ($-0.31).
How does Quest PharmaTech Inc.'s earnings per share (EPS) compare with similar companies?
Quest PharmaTech Inc.'s earnings per share (EPS) ($0.02) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.